Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Mar 27, 2013; 5(3): 97-103
Published online Mar 27, 2013. doi: 10.4254/wjh.v5.i3.97
Published online Mar 27, 2013. doi: 10.4254/wjh.v5.i3.97
Table 4 The relationship of the genotypes of low molecular polypeptide-7 gene polymorphism within different liver fibrosis and activity stages in sustained virological response and non-response groups after treatment n (%)
| AA (n = 14) | CA (n = 42) | CC (n = 48) | P value | |
| F0 (n = 10) | 1 (10.00) | 2 (20) | 7 (70) | 0.045 |
| F1 (n = 29) | 4 (13.79) | 7 (24.14) | 18 (62.07) | 0.004 |
| F2 (n = 36) | 4 (11.11) | 14 (38.89) | 18 (50.00) | 0.013 |
| F3 (n = 23) | 4 (17.39) | 14 (60.87) | 5 (21.74) | 0.019 |
| F4 (n = 6) | 1 (16.67) | 5 (83.33) | 0 (0) | 0.1021 |
| A0 (n = 10) | 1 (11.11) | 1 (11.11) | 7 (77.78) | 0.018 |
| A1 (n = 29) | 9 (14.52) | 19 (30.65) | 34 (54.84) | 0.001 |
| A2 (n = 36) | 3 (11.11) | 18 (66.67) | 6 (22.22) | 0.001 |
| A3 (n = 6) | 1 (16.67) | 4 (66.67) | 1 (16.67) | 0.023 |
- Citation: Omran MH, Fotouh BE, Youssef SS, Ibrahim NE, Nabil W, Mahdy ESM, Shosha WG, El-Awady MK. Association between low molecular polypeptide 7 single nucleotide polymorphism and response to therapy in hepatitis C virus infection. World J Hepatol 2013; 5(3): 97-103
- URL: https://www.wjgnet.com/1948-5182/full/v5/i3/97.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i3.97